沪深市场个股详情

600222 太龙药业

添加自选

5.03
+0.02+0.40%

交易中 04/29 09:54 (北京)

28.87亿总市值47.01市盈率TTM

太龙药业股票讨论区

登录发表评论

Moomoo AI

02/06 07:35

Market expectations of a decline in Henan Taloph Pharmaceutical's revenue performance and slower growth compared to the industry average may contribute to its low P/S ratio. Shareholders' wariness of the company's ability to keep up with industry growth could be a factor in the declining share price.

Why Investors Shouldn't Be Surprised By Henan Taloph Pharmaceutical Stock Co.,Ltd's (SHSE:600222) 30% Share Price Plunge

Moomoo AI

2023/10/31 08:13

Henan Taloph's lower P/S ratio may be justified due to slower growth rates than industry rivals. Doubts about the company's ability to maintain robust growth in line with industry may hinder share price recovery.

Little Excitement Around Henan Taloph Pharmaceutical Stock Co.,Ltd's (SHSE:600222) Revenues

暂无评论

分析

分析师评级

暂无数据

目标价预测

暂无数据

热议

沪深

综合热度